JWEL · Jowell Global
Conviction · Low · more likely to lag the S&P 500 over the next three months
Wrong if: a daily close above $2.20
Note written ·
Price against the kill line
21.4% clear of its kill line on the 13 November 2026 close.
How to read this
This note expects the shares to lag the market, so its kill line sits above the price: a close above the red mark would prove the view wrong. Prices run from low on the left to high on the right. The dot is where the stock closed on 13 November 2026, left of the mark while it is below the line; a dot right of the mark has closed through it.
The scale is stretched near the line, so close calls are easy to see. More than 8% from the line, the stock reads well clear, with a hollow dot to show the figure is off the drawn scale.
The kill line is the research note's own test. The portfolio sells on business facts, not on a price. How the portfolio decides
Three months against the kill line
Daily closes, to . Red: the kill line, a daily close above $2.20, on record since 11 November 2026. The shares are down 36.4% since the close; the S&P 500 is down 2.1% over the same sessions. Figures in the note can cover a different window.
Kill line
A daily close above $2.20, which is above the 50-day average of closes and would show the shares leading the S&P 500 again. First-half 2026 results showing a net profit would also show the shares leading.
Research onlyNot in the portfolio.
Key figures from the filings · Consumer Discretionary
Filed figures are not available: no quarterly report in US GAAP with the SEC (a foreign filer reports on Form 20-F or 40-F).
All filed numbers
What Jowell Global reports to the SEC in its quarterly and annual filings. Each group states its period and filing date once; a figure dated otherwise says so. Built from the filings known on .
Short interest (FINRA, settled 15 October 2026, published 26 October 2026): the share of shares outstanding is not available, 1.0 days of average trading to cover, −27.1% since the previous report.
| Window | Bought | Sold |
|---|---|---|
| 90 daysfrom | $0 | $0 |
| 12 monthsfrom | $0 | $0 |
The thesis
Jowell Global, a China-based online seller of health supplements, cosmetics and household goods, is more likely to lag the S&P 500 over the next three months. The shares closed at $1.73 on 12 November 2026, down 44.0% in three months, and no company filing explains the August spike or its unwinding. The half-year results expected around December 2026 are the next scheduled test.
The $1.73 close sits below the 50-day average of $2.19 and the 200-day average of $2.30 (adjusted daily closes, as of 12 November 2026). It is 66.5% below the 52-week intraday high of $5.17 set on 10 August 2026. The 52-week closing low is $1.55, set on 7 August 2026, three sessions before the spike.
Company news shows no release in the 30 days to 12 November 2026. The shares appeared in Benzinga's 6 November 2026 consumer discretionary pre-market movers list and closed at $1.84 that day, up from $1.71 on 5 November 2026. They closed at $1.73 on 12 November 2026, so the rebound did not hold.
Bullish and bearish views on Jowell Global Ltd.
The bull case on Jowell Global Ltd. (JWEL), in brief: revenue is growing. The bear case: the August spike had no filing behind it.
Bull case
- Revenue is growing. The fiscal 2025 annual report (Form 20-F, filed 30 April 2026) shows revenue of $165.00 million, up 24.1% from the prior year.
- The float is very small. The same 20-F reports 2,376,131 ordinary shares outstanding at 31 December 2025. Benzinga reported the shares up 106.1% to $3.19 in the regular session on 10 August 2026, so small order flow has moved the price sharply before.
- The price has held above the August low. The $1.73 close on 12 November 2026 is above the $1.55 closing low of 7 August 2026, and the six closes from 5 November to 12 November 2026 ranged between $1.71 and $1.84.
Bear case
- The August spike had no filing behind it. Benzinga's 10 August 2026 movers lists show the move, and the company has issued no news in the 30 days to 12 November 2026. The price rested on trading flow, and the three-month change of −44.0% shows that flow has reversed.
- The shares trade under both major averages. The 12 November 2026 close of $1.73 is below the 50-day average of $2.19 and the 200-day average of $2.30.
- Revenue has not become profit. Fiscal 2025 net loss was $6.28 million on $165.00 million of revenue (Form 20-F, filed 30 April 2026).
- Registered issuance capacity dwarfs the market value. A Form F-3 filed 26 August 2025 registers up to $118.9 million of mixed securities. Benzinga put the market capitalisation at $3.6 million on 10 August 2026. One placement could change the share count by a multiple and would arrive as a Form 6-K or prospectus supplement with no advance notice.
- The company has leaned on its largest shareholder. Panabee reported that a $2.8 million private placement in November 2025 was replaced by a promissory note from major shareholder Jowell Holdings Ltd. Funding has come from an insider rather than the open market.
Price setup
Reference levels from daily closes as of 12 November 2026: last close $1.73; 50-day average $2.19; 200-day average $2.30; 52-week closing low $1.55 (7 August 2026); 52-week intraday high $5.17 (10 August 2026). The 3-month reference close was $3.09 on 14 August 2026.
A close below $1.55 would be a new 52-week closing low and would put the shares below every close since the spike began. Nasdaq's minimum bid price rule sets $1.00 as the listing threshold, which is 42% under the last close.
Trading is thin. With about 2.38 million shares outstanding at 31 December 2025, single prints can move the price several percent in either direction, as the $1.71 to $1.84 swing between 5 November 2026 and 6 November 2026 shows.
Catalysts ahead
- ~December 2026 (est.): First-half 2026 unaudited results on Form 6-K. The first-half 2025 comparison was $76.2 million revenue, $59.4 million supplement revenue and a $1.3 million net loss; this report shows whether losses are narrowing.
- ~April 2027 (est.): Fiscal 2026 annual report on Form 20-F. Audited full-year figures, cash position and any going-concern language, against fiscal 2025 revenue of $165.00 million and a $6.28 million net loss.
What would change the view
A daily close above $2.20, which is above the 50-day average of closes and would show the shares leading the S&P 500 again. First-half 2026 results showing a net profit would also show the shares leading.
What it trades with
No theme cluster drives this name. The shares trade on thin-float order flow and on sentiment toward small China-based e-commerce companies. Benzinga's consumer discretionary movers lists carried them alongside unrelated microcaps on 10 August 2026 and again on 6 November 2026. Two appearances are too few to support a conclusion about a common driver.
The evidence, claim by claim (6)
- Closed at $1.73; the 50-day average of closes was $2.19, the 200-day average $2.30, and the three-month price change was −44.0%. Adjusted daily closes · as of
- The 52-week intraday high was $5.17 on 10 August 2026; the 52-week closing low was $1.55 on 7 August 2026. Daily price history · as of
- Shares rose 106.1% to $3.19 in the regular session; pre-market they were up 219.3% to $4.95; market capitalisation was $3.6 million. Benzinga consumer discretionary movers lists · as of
- Fiscal 2025 revenue was $165.00 million, up 24.1%; net loss was $6.28 million; 2,376,131 ordinary shares were outstanding. Fiscal 2025 Form 20-F, filed 30 April 2026 · as of
- A Form F-3 registered up to $118.9 million of mixed securities. Form F-3 filed 26 August 2025 · as of
- A $2.8 million private placement was replaced by a promissory note from major shareholder Jowell Holdings Ltd. Panabee report on Form 6-K, November 2025 · as of
Sources